Connection

Alicia Jenkins to Risk Factors

This is a "connection" page, showing publications Alicia Jenkins has written about Risk Factors.
Connection Strength

0.865
  1. Shorter telomeres in adults with Type 1 diabetes correlate with diabetes duration, but only weakly with vascular function and risk factors. Diabetes Res Clin Pract. 2016 Jul; 117:4-11.
    View in: PubMed
    Score: 0.066
  2. Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients. J Diabetes Complications. 2014 May-Jun; 28(3):353-9.
    View in: PubMed
    Score: 0.056
  3. Associations among smoking status, lifestyle and lipoprotein subclasses. J Clin Lipidol. 2010 Nov-Dec; 4(6):522-30.
    View in: PubMed
    Score: 0.045
  4. Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort. J Diabetes Complications. 2008 May-Jun; 22(3):153-63.
    View in: PubMed
    Score: 0.038
  5. Systemic and vascular inflammation is elevated in early IgA and type 1 diabetic nephropathies and relates to vascular disease risk factors and renal function. Nephrol Dial Transplant. 2005 Nov; 20(11):2420-6.
    View in: PubMed
    Score: 0.031
  6. Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia. Diabetes Care. 2003 Mar; 26(3):810-8.
    View in: PubMed
    Score: 0.026
  7. Optimal Frequency of Retinopathy Screening in Adolescents With Type 1 Diabetes: Markov Modeling Approach Based on 30 Years of Data. Diabetes Care. 2022 10 01; 45(10):2383-2390.
    View in: PubMed
    Score: 0.026
  8. Retinopathy risk calculators in the prediction of sight-threatening diabetic retinopathy in type 2 diabetes: A FIELD substudy. Diabetes Res Clin Pract. 2022 Apr; 186:109835.
    View in: PubMed
    Score: 0.025
  9. Baseline extended zone retinal vascular calibres associate with sensory nerve abnormalities in adolescents with type 1 diabetes: A prospective longitudinal study. Diabet Med. 2021 11; 38(11):e14662.
    View in: PubMed
    Score: 0.024
  10. Skin autofluorescence is associated with higher risk of cardiovascular events in Chinese adults with type 2 diabetes: A prospective cohort study from the Hong Kong Diabetes Biobank. J Diabetes Complications. 2021 10; 35(10):108015.
    View in: PubMed
    Score: 0.024
  11. Metformin and carotid intima-media thickness in never-smokers with type 1 diabetes: The REMOVAL trial. Diabetes Obes Metab. 2021 06; 23(6):1371-1378.
    View in: PubMed
    Score: 0.023
  12. Diabetes, metabolic disease, and telomere length. Lancet Diabetes Endocrinol. 2021 02; 9(2):117-126.
    View in: PubMed
    Score: 0.023
  13. Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study. Diabetes Res Clin Pract. 2020 Nov; 169:108450.
    View in: PubMed
    Score: 0.022
  14. Shortened Relative Leukocyte Telomere Length Is Associated With Prevalent and Incident Cardiovascular Complications in Type 2 Diabetes: Analysis From the Hong Kong Diabetes Register. Diabetes Care. 2020 09; 43(9):2257-2265.
    View in: PubMed
    Score: 0.022
  15. Extended-Zone Retinal Vascular Caliber and Risk of Diabetic Retinopathy in Adolescents with Type 1 Diabetes. Ophthalmol Retina. 2020 12; 4(12):1151-1157.
    View in: PubMed
    Score: 0.022
  16. Uric acid predicts long-term cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The FIELD study. Diabetes Obes Metab. 2020 08; 22(8):1388-1396.
    View in: PubMed
    Score: 0.022
  17. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 10 01; 104(10):4743-4755.
    View in: PubMed
    Score: 0.021
  18. Effect of a high-egg diet on cardiometabolic risk factors in people with type 2 diabetes: the Diabetes and Egg (DIABEGG) Study-randomized weight-loss and follow-up phase. Am J Clin Nutr. 2018 06 01; 107(6):921-931.
    View in: PubMed
    Score: 0.019
  19. Incidence and Mortality Rates and Clinical Characteristics of Type 1 Diabetes among Children and Young Adults in Cochabamba, Bolivia. J Diabetes Res. 2017; 2017:8454757.
    View in: PubMed
    Score: 0.018
  20. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. 2017 08; 5(8):597-609.
    View in: PubMed
    Score: 0.018
  21. Progressive Retinal Vasodilation in Patients With Type 1 Diabetes: A Longitudinal Study of Retinal Vascular Geometry. Invest Ophthalmol Vis Sci. 2017 05 01; 58(5):2503-2509.
    View in: PubMed
    Score: 0.018
  22. Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial. Diabetes Obes Metab. 2017 04; 19(4):509-516.
    View in: PubMed
    Score: 0.017
  23. Muscle grip strength predicts incident type 2 diabetes: Population-based cohort study. Metabolism. 2016 06; 65(6):883-92.
    View in: PubMed
    Score: 0.016
  24. Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia. 2015 Sep; 58(9):2035-44.
    View in: PubMed
    Score: 0.015
  25. Sex differences in retinal microvasculature through puberty in type 1 diabetes: are girls at greater risk of diabetic microvascular complications? Invest Ophthalmol Vis Sci. 2014 Dec 04; 56(1):571-7.
    View in: PubMed
    Score: 0.015
  26. The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study. Diabetologia. 2015 Mar; 58(3):464-73.
    View in: PubMed
    Score: 0.015
  27. The metabolic syndrome and CVD outcomes for a central Australian cohort. Diabetes Res Clin Pract. 2013 Jun; 100(3):e70-3.
    View in: PubMed
    Score: 0.013
  28. Long-term fenofibrate therapy increases fibroblast growth factor 21 and retinol-binding protein 4 in subjects with type 2 diabetes. J Clin Endocrinol Metab. 2012 Dec; 97(12):4701-8.
    View in: PubMed
    Score: 0.013
  29. High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes. Diabetes Care. 2012 Jun; 35(6):1333-40.
    View in: PubMed
    Score: 0.012
  30. Plantar fascia thickness is longitudinally associated with retinopathy and renal dysfunction: a prospective study from adolescence to adulthood. J Diabetes Sci Technol. 2012 Mar 01; 6(2):348-55.
    View in: PubMed
    Score: 0.012
  31. Thioflavin T fluorescence in human serum: correlations with vascular health and cardiovascular risk factors. Clin Biochem. 2010 Feb; 43(3):278-86.
    View in: PubMed
    Score: 0.010
  32. Retinal vascular fractal dimension and risk of early diabetic retinopathy: A prospective study of children and adolescents with type 1 diabetes. Diabetes Care. 2009 Nov; 32(11):2081-3.
    View in: PubMed
    Score: 0.010
  33. Lipid treatment guidelines and cardiovascular risk for Aboriginal people in Central Australia. Med J Aust. 2009 May 18; 190(10):552-6.
    View in: PubMed
    Score: 0.010
  34. C-reactive protein concentrations are very high and more stable over time than the traditional vascular risk factors total cholesterol and systolic blood pressure in an Australian aboriginal cohort. Clin Chem. 2009 Feb; 55(2):336-41.
    View in: PubMed
    Score: 0.010
  35. Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complications. Diabetes Care. 2008 Oct; 31(10):2006-12.
    View in: PubMed
    Score: 0.010
  36. Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care. 2008 Sep; 31(9):1842-6.
    View in: PubMed
    Score: 0.010
  37. Increased methionine sulfoxide content of apoA-I in type 1 diabetes. J Lipid Res. 2008 Apr; 49(4):847-55.
    View in: PubMed
    Score: 0.009
  38. Low-density lipoprotein particles and risk of intracerebral haemorrhage in subjects with cerebrovascular disease. Eur J Cardiovasc Prev Rehabil. 2007 Jun; 14(3):413-8.
    View in: PubMed
    Score: 0.009
  39. Cardiovascular risk factors in pre-pubertal Malays: effects of diabetic parentage. Diabetes Res Clin Pract. 2007 Apr; 76(1):119-25.
    View in: PubMed
    Score: 0.008
  40. Retinal vascular caliber and risk of retinopathy in young patients with type 1 diabetes. Ophthalmology. 2006 Sep; 113(9):1499-503.
    View in: PubMed
    Score: 0.008
  41. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke. 2005 Oct; 36(10):2143-7.
    View in: PubMed
    Score: 0.008
  42. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial. Circulation. 2005 May 17; 111(19):2446-53.
    View in: PubMed
    Score: 0.008
  43. Apolipoprotein C-III protein concentrations and gene polymorphisms in Type 1 diabetes: associations with microvascular disease complications in the DCCT/EDIC cohort. J Diabetes Complications. 2005 Jan-Feb; 19(1):18-25.
    View in: PubMed
    Score: 0.008
  44. Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease. Hypertension. 2005 Jan; 45(1):69-74.
    View in: PubMed
    Score: 0.007
  45. Apolipoprotein C-III protein concentrations and gene polymorphisms in type 1 diabetes: associations with lipoprotein subclasses. Metabolism. 2004 Oct; 53(10):1296-304.
    View in: PubMed
    Score: 0.007
  46. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Diabetes Care. 2004 Apr; 27(4):978-83.
    View in: PubMed
    Score: 0.007
  47. Inflammation and vascular endothelial activation in an Aboriginal population: relationships to coronary disease risk factors and nutritional markers. Med J Aust. 2003 May 19; 178(10):495-500.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.